This RSA section is an unofficial mirror, is not legal advice, and may be incomplete, outdated, or incorrectly processed.

RSA 329:9 · Rulemaking Authority

329:9 Rulemaking Authority. – The board shall adopt rules, pursuant to RSA 541-A, relative to:

Copy link
I.

[Repealed.]

Copy link
II.

The qualifications of applicants for initial and continued licensure consistent with the provisions of this chapter.

Copy link
III.

[Repealed.]

Copy link
IV.

The procedural and substantive requirements for the reinstatement of licenses after lapses, inactive status, voluntary surrender, or disciplinary action consistent with this chapter.

Copy link
V.

Ethical and professional standards required to be met by each holder of a license to practice medicine.

Copy link
VI.

[Repealed.]

Copy link
VII.

[Repealed.]

Copy link
VIII.

The circumstances under which restricted licenses are to be issued.

Copy link
IX.

[Repealed.] X-XII. [Repealed.]

Copy link
XIII.

[Repealed.]

Copy link
XIV.

The licensing of physician associates as provided in RSA 328-D:2.

Copy link
XV.

Substantive requirements for assessing administrative fines against licensees as authorized under RSA 310:12 and against licensees and nonlicensees as authorized by RSA 329:2, II(d). XV-a. Procedures for appropriate pain management pursuant to RSA 318-B:10, IX.

Copy link
XVI.

[Repealed.]

Copy link
XVII.

The establishment of a panel of clinician licensees to assist the office in carrying out its investigative obligations under RSA 310, provided that committee appointments shall be made by the executive director in accordance with criteria established by the board.

Copy link
XVIII.

[Repealed.]

Copy link
XIX.

[Repealed.]

Copy link
XX.

Prescribing controlled drugs pursuant to RSA 318-B:41.

Copy link
XXI.

[Repealed.]

Copy link
XXII.

Review of complaints asserting a violation of RSA 329:31-c, relative to appropriate reproductive care for medical conditions, including disciplinary proceedings under RSA 310:10 and assessment of fines under RSA 310:12. Source. 1951, 27:4. RSA 329:9. 1977, 417:4. 1981, 483:4. 1986, 219:7, 8. 1987, 330:2. 1992, 179:2. 1993, 179:2. 1995, 286:6-8, 28, III, IV. 1997, 287:56, 59, LXI-LXIII. 2000, 286:3. 2008, 21:6, III. 2009, 206:6, 7. 2012, 171:26, XV. 2016, 213:2, eff. June 7, 2016. 2020, 27:13, eff. July 21, 2020. 2021, 197:78, III, eff. July 1, 2021. 2023, 212:20, II, eff. Oct. 3, 2023; 212:64, 65, I, II, eff. July 1, 2023 at 12:01 a.m. 2024, 352:3, 13, I, eff. Oct. 1, 2024. 2025, 105:2, eff. June 17, 2025; 199:2, eff. Sept. 13, 2025.

Copy link

Source note

Source. 1951, 27:4. RSA 329:9. 1977, 417:4. 1981, 483:4. 1986, 219:7, 8. 1987, 330:2. 1992, 179:2. 1993, 179:2. 1995, 286:6-8, 28, III, IV. 1997, 287:56, 59, LXI-LXIII. 2000, 286:3. 2008, 21:6, III. 2009, 206:6, 7. 2012, 171:26, XV. 2016, 213:2, eff. June 7, 2016. 2020, 27:13, eff. July 21, 2020. 2021, 197:78, III, eff. July 1, 2021. 2023, 212:20, II, eff. Oct. 3, 2023; 212:64, 65, I, II, eff. July 1, 2023 at 12:01 a.m. 2024, 352:3, 13, I, eff. Oct. 1, 2024. 2025, 105:2, eff. June 17, 2025; 199:2, eff. Sept. 13, 2025.

Source history

  • 1951, 27:4. RSA 329:9
  • 1977, 417:4
  • 1981, 483:4
  • 1986, 219:7, 8
  • 1987, 330:2
  • 1992, 179:2
  • 1993, 179:2
  • 1995, 286:6-8, 28, III, IV
  • 1997, 287:56, 59, LXI-LXIII
  • 2000, 286:3
  • 2008, 21:6, III
  • 2009, 206:6, 7
  • 2012, 171:26, XV
  • 2016, 213:2, eff. June 7, 2016
  • 2020, 27:13, eff. July 21, 2020
  • 2021, 197:78, III, eff. July 1, 2021
  • 2023, 212:20, II, eff. Oct. 3, 2023; 212:64, 65, I, II, eff. July 1, 2023 at 12:01 a.m
  • 2024, 352:3, 13, I, eff. Oct. 1, 2024
  • 2025, 105:2, eff. June 17, 2025; 199:2, eff. Sept. 13, 2025

Related materials

Bill relationships

  • 2026 HB1292 reference · effective 2027-01-01

    withstanding any provision of law to the contrary, the board of medicine shall not revoke, fail to renew, or take any other action against a physician's license issued pursuant to RSA 329 based primarily on a physician's recommendation to [an eligible] a patient regarding or prescription for or treatment with [an investigational] a drug, biologic, or device pursuant to this chapter. II. Notwithstandi

  • 2026 HB1292-FN reference · effective 2027-01-01

    withstanding any provision of law to the contrary, the board of medicine shall not revoke, fail to renew, or take any other action against a physician's license issued pursuant to RSA 329 based primarily on a physician's recommendation to [an eligible] a patient regarding or prescription for or treatment with [an investigational] a drug, biologic, or device pursuant to this chapter. II. Notwithstandi

  • 2026 HB1321 amend

    ravenous therapy. Be it Enacted by the Senate and House of Representatives in General Court convened: 1 New Subdivision; Provision of Elective Intravenous Therapy. Amend RSA 329 by inserting after section 53 the following new subdivision: Provision of Elective Intravenous Therapy 329:54 Definitions. As used in this subdivision, "elective intravenous therapy" means a procedure: I. To admin

  • 2026 HB1335 amend · effective 2027-01-01

    use of Representatives in General Court convened: 1 New Subdivision; Physicians and Surgeons; Disclosure of Preferential Promotion Received by Provider; When Required. Amend RSA 329 by inserting after section 53 the following new subdivision: Disclosure of Preferential Promotion 329:54 Definitions. In this subdivision: (a) “Preferential promotion” means any financial arrangement, incentiv

  • 2026 HB1702 amend

    seeking chemical abortions that it may be possible to undo the effects of mifepristone, a drug commonly used to induce abortions. 2 New Subdivision; Chemical Abortion. Amend RSA 329 by inserting after section 53 the following new subdivision: Chemical Abortion 329:54 Definitions. In this subdivision: I. "Chemical abortion" or "medical abortion" means the use or prescription of any drug or

  • 2026 HB1702-FN amend

    seeking chemical abortions that it may be possible to undo the effects of mifepristone, a drug commonly used to induce abortions. 2 New Subdivision; Chemical Abortion. Amend RSA 329 by inserting after section 53 the following new subdivision: Chemical Abortion 329:54 Definitions. In this subdivision: I. "Chemical abortion" or "medical abortion" means the use or prescription of any drug or

  • 2026 HB1735 reference

    withstanding any provision of law to the contrary, the board of medicine shall not revoke, fail to renew, or take any other action against a physician's license issued pursuant to RSA 329 based primarily on a physician's recommendation to [an eligible] a patient regarding or prescription for or treatment with [an investigational] a drug, biologic, or device pursuant to this chapter. II. Notwithstandi

  • 2026 HB1735-FN reference

    withstanding any provision of law to the contrary, the board of medicine shall not revoke, fail to renew, or take any other action against a physician's license issued pursuant to RSA 329 based primarily on a physician's recommendation to [an eligible] a patient regarding or prescription for or treatment with [an investigational] a drug, biologic, or device pursuant to this chapter. II. Notwithstandi

  • 2026 HB1769 amend · effective 2027-01-01

    d medical facilities. Be it Enacted by the Senate and House of Representatives in General Court convened: 1 New Subdivision; Public Funding and Abortion Referrals. Amend RSA 329 by inserting after section 50 the following new subdivision: Public Funding and Abortion Referrals 329:50-a Definitions. I. "Abortion" shall have the same meaning as provided in RSA 132:32, I. II. "Medical fa

  • 2026 HB1769-FN amend · effective 2027-01-01

    d medical facilities. Be it Enacted by the Senate and House of Representatives in General Court convened: 1 New Subdivision; Public Funding and Abortion Referrals. Amend RSA 329 by inserting after section 50 the following new subdivision: Public Funding and Abortion Referrals 329:50-a Definitions. I. "Abortion" shall have the same meaning as provided in RSA 132:32, I. II. "Medical fa

  • 2026 HB1772 amend

    ct. Be it Enacted by the Senate and House of Representatives in General Court convened: 1 New Section; Ibogaine; Administered Under FDA-approved Research Protocol. Amend RSA 329 by inserting after section RSA 329:1-h the following new section: 329:1-i Ibogaine; Administered Under FDA-approved Research Protocol. To the extent allowable by federal law, licensed physicians or qualified licensed

  • 2026 HB1772-FN-A amend

    ct. Be it Enacted by the Senate and House of Representatives in General Court convened: 1 New Section; Ibogaine; Administered Under FDA-approved Research Protocol. Amend RSA 329 by inserting after section RSA 329:1-h the following new section: 329:1-i Ibogaine; Administered Under FDA-approved Research Protocol. To the extent allowable by federal law, licensed physicians or qualified licensed